EIX vs MDGL · P/E 7.3, rev $17.60B vs rev $180.1M
Edison International (EIX) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the EIX and MDGL stock pages for the full models.
Not investment advice.